An International Multicentre, Phase 2, Randomised, Adaptive Protocol to determine the need for, optimal timing of and immunogenicity of administering a booster mRNA vaccination dose against SARS-CoV-2 in the general population (18+ years) already vaccinated against SARS-CoV-2
Lead: Patrick Mallon, Institution/Sponsor: NUID UCD, Ireland
EudraCT-number: 2021-004889-35
Details:
https://twitter.com/vaccelerate_eu/status/1503688207506063360
https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-004889-35/IE